CX3CR1+ DCs express high levels of PD-L1 (CD274) and PD-L2 (PDCD1LG2) in AML, which mediate T cell suppression and immunosuppressive TME formation [85]. The gene discussed is CX3CR1; the disease is acute myeloid leukemia.